California State University  (CSU) Chancellor's Office

CSU Expands Vaccine Availability with New Partnerships

Many CSU campuses now offer even more options for students and employees to get their COVID-19 shots, thanks to unique partnerships with national pharmacies and local hospitals.

Newswise — In an effort to make the COVID-19 vaccine readily available to its campus communities, the CSU has partnered with national pharmacies and area hospitals to offer free local pop-up clinics specifically for CSU students and employees. While many CSU campuses already serve as vaccination sites for the broader community, these new clinics represent a unique public-private partnership between the university and pharmacies such as Rite Aid, Albertsons/Safeway, CVS and Walmart.  

“The CSU is thrilled to be able to partner with major national pharmacies to bring the COVID-19 vaccine directly to our campuses,” says Jenny Novak, director of systemwide emergency management and continuity at the CSU Chancellor’s Office. “We highly encourage all CSU students, staff and faculty to take advantage of these free and convenient vaccination days just for our communities. Through these partnerships, we are actively doing our part to help the state achieve its vaccination and immunity goals.” 

For example, both CSU Channel Islands and Cal Poly San Luis Obispo partnered with Rite Aid to offer first-dose COVID-19 vaccines on April 29 and will begin second-dose appointments on May 20. Chico State has also partnered with Rite Aid to offer a clinic on May 11, and Cal State Fullerton has partnered with Providence St. Jude Medical Center to make COVID-19 vaccinations available to all faculty, staff, students and their immediate family members living in Southern California.   

Interested students and employees should visit their CSU campus coronavirus information website or contact their office of student affairs or human resources department for information.   

On April 22, the CSU announced plans to implement a fall 2021 term COVID-19 vaccination requirement upon FDA approval of one or more of the vaccines. The proposed policy—still in development—would require all students, faculty and staff to be vaccinated before accessing any campus facilities. In addition, the American College Health Association urges college students to schedule their COVID-19 vaccine as soon as possible and not to delay initiation until they reach their summer destination. 

As part of its commitment to safeguarding the health and safety of its students and employees, the CSU will continue to assess the needs of its campuses and may consider offering additional clinics closer to the start of the fall semester.  



Filters close

Showing results

110 of 5870
Released: 24-Jun-2021 12:30 PM EDT
A tecnologia de IA e ECG pode descartar rapidamente a infecção por COVID-19, concluiu o estudo da Mayo Clinic
Mayo Clinic

A inteligência artificial (IA) pode oferecer uma maneira de determinar com precisão se uma pessoa não está infectada com a COVID-19. Um estudo retrospectivo internacional descobriu que a infecção pelo SARS-CoV-2, o vírus que causa a COVID-19, cria mudanças elétricas sutis no coração. Um eletrocardiograma (ECG) habilitado com IA pode detectar essas alterações e, potencialmente, ser usado como um teste de triagem rápido e confiável para descartar a infecção por COVID-19.

Released: 24-Jun-2021 12:10 PM EDT
妙佑医疗国际(Mayo Clinic)的研究发现,AI赋能的心电图技术有可能迅速排除COVID-19感染
Mayo Clinic

AI (人工智能)有可能提供准确判断一个人未感染COVID-19(2019冠状病毒病)的方法。一项国际回顾性研究发现,如果感染了导致COVID-19的SARS-CoV-2病毒,患者的心脏会产生微妙的电学变化。AI赋能的心电图(EKG)可以检测到这些变化,并有望被用于进行快速、可靠的COVID-19筛查检测,以排除COVID-19感染。

Newswise: 200421_Felgner_3205_sz-2-768x496.jpg
Released: 24-Jun-2021 11:50 AM EDT
UCI Professor Wins Spain’s Prestigious Princess of Asturias Award for Scientific Research
University of California, Irvine

Irvine, Calif., June 24, 2021 — Philip Felgner, Ph.D., professor in residence of physiology & biophysics at the University of California, Irvine, is one of seven scholars worldwide to win Spain’s prestigious Princess of Asturias Award for Technical and Scientific Research in recognition of their contributions to designing COVID-19 vaccines.

Released: 24-Jun-2021 11:00 AM EDT
New protein engineering method could accelerate the discovery of COVID-19 therapeutics
University of Michigan

Discovering and engineering nanobodies with properties suitable for treating human diseases ranging from cancer to COVID-19 is a time-consuming, laborious process.

Newswise: Decoding humans’ survival from coronaviruses
Released: 24-Jun-2021 11:00 AM EDT
Decoding humans’ survival from coronaviruses
University of Adelaide

An international team of researchers co-led by the University of Adelaide and the University of Arizona has analysed the genomes of more than 2,500 modern humans from 26 worldwide populations, to better understand how humans have adapted to historical coronavirus outbreaks.

access_time Embargo lifts in 2 days
Embargo will expire: 29-Jun-2021 4:00 PM EDT Released to reporters: 24-Jun-2021 10:35 AM EDT

A reporter's PressPass is required to access this story until the embargo expires on 29-Jun-2021 4:00 PM EDT The Newswise PressPass gives verified journalists access to embargoed stories. Please log in to complete a presspass application. If you have not yet registered, please Register. When you fill out the registration form, please identify yourself as a reporter in order to advance to the presspass application form.

Newswise: COVIDLockdownSimulations.jpg
Released: 24-Jun-2021 10:00 AM EDT
Pandemic Air Quality Affected By Weather, Not Just Lockdowns
Washington University in St. Louis

Using a diverse set of tools, the lab of Randall Martin shows how the pandemic did – or didn’t – affect levels of particulate matter during COVID lockdowns.

Released: 24-Jun-2021 6:05 AM EDT
Longest known SARS-CoV-2 infection of nearly 300 days successfully treated with new therapy
University of Bristol

An immunocompromised individual with the longest known PCR confirmed case of SARS-CoV-2 infection, lasting more than 290 days, has been successfully treated with two investigational monoclonal antibodies (laboratory engineered antibodies). Clinicians and researchers from the University of Bristol and North Bristol NHS Trust (NBT) worked closely to assess and treat the infection and want to highlight the urgent need for improved access to treatments for such people with persistent SARS-CoV-2 infection.

Released: 23-Jun-2021 3:55 PM EDT
Cooperative Extension grant aims to vaccinate NYS’ vulnerable
Cornell University

A two-year, $200,000 grant from the USDA and the Extension Foundation to Cornell University researchers aims to help promote vaccine confidence and uptake in vulnerable communities in eight New York counties, both upstate and downstate.

Released: 23-Jun-2021 12:10 PM EDT
Phone swabs can accurately detect COVID-19
University College London

An accurate, non-invasive, and low-cost method of testing for COVID-19 using samples taken from the screens of mobile phones has been developed by a team led by UCL researchers at Diagnosis Biotech.


Showing results

110 of 5870

close
1.98472